Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016330	du-k	— (—)	625	804	100.00%	Distribution not available
3016330	du-k	mmol/24h (mmol/24h)	19	19	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Endocrine, nutritional and metabolic diseases

134

136

5.00

47.52

1.3

1.2

89.16

77.51

mmol/24h

—

All chronic kidney diseases

105

222

3.88

33.65

1.3

1.2

—

88.92

—

Migraine

216

2.97

17.06

1.3

1.2

—

76.90

—

Abnormalities of heart beat

161

3.42

15.98

1.3

1.2

—

95.07

—

General symptoms and signs

149

343

2.18

15.15

1.3

96.98

71.27

mmol/24h

—

Renal tubulo-interstitial diseases

126

420

2.24

15.13

1.2

—

78.77

—

Headache

319

2.46

14.76

1.2

1.3

—

71.27

—

Renal failure

196

2.98

14.73

1.3

1.2

—

89.12

—

Persons encountering health services in other circumstances

242

2.80

13.97

1.3

1.2

—

87.27

—

Disorders of lipoprotein metabolism and other lipidaemias

226

2.52

13.75

1.3

1.2

—

84.93

—

Type 2 diabetes, wide definition

108

302

2.29

13.29

1.3

1.2

—

84.81

—

Other heart diseases, wide

131

378

2.12

13.26

1.3

1.2

83.28

77.63

mmol/24h

—

Disorders of the thyroid gland

132

421

2.04

12.37

1.2

92.06

71.21

mmol/24h

—

Disorders resulting from impaired renal tubular function

16.57

11.68

1.3

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

128

418

2.01

11.54

1.3

1.2

96.30

70.86

mmol/24h

—

Hypotension

4.51

11.39

1.2

1.3

—

Hypothyroidism, other/unspecified

123

402

2.01

11.17

1.3

1.2

96.30

71.21

mmol/24h

—

Obesity related asthma

203

2.71

10.76

1.3

1.2

—

86.64

—

Glucagon-like peptide-1 (GLP-1) analogues

166

2.90

10.60

1.3

1.2

—

87.10

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

166

2.90

10.60

1.3

1.2

—

87.10

—

Intestinal infectious diseases

125

496

1.91

10.18

1.3

1.2

—

80.34

—

Exposure to unspecified factor

132

506

1.88

10.07

1.1

1.3

—

78.89

—

Diarrhoea and gastroenteritis of presumed infectious origin

421

2.03

9.53

1.3

1.2

—

81.35

—

Asthma, excluding more controls

104

264

2.06

9.48

1.3

—

86.25

—

Other antidepressants

130

352

1.89

9.41

1.3

1.2

84.80

79.49

mmol/24h

—

Hyperkalaemia

17.59

9.40

1.1

—

Other septicaemia

192

2.61

9.39

1.3

1.2

—

88.13

—

Asthma

105

277

1.99

8.82

1.3

1.2

—

86.25

—

Use of pramipexole

108

3.16

8.74

1.2

—

87.32

—

Asthma, unspecified (mode), excluding more controls

244

2.21

8.64

1.3

—

86.25

—

Migraine with aura

114

3.08

8.63

1.3

1.2

—

87.46

—

Asthma (mode)

103

280

1.97

8.51

1.3

—

86.25

—

Other systemic involvement of connective tissue (FG)

120

2.97

8.34

1.1

1.2

—

91.09

—

Adverse effects, not elsewhere classified

101

3.18

8.33

1.1

1.3

—

97.62

—

Pure hypercholesterolaemia

206

2.22

8.24

1.3

1.2

—

84.93

—

Fever of other and unknown origin

274

2.18

8.08

1.2

—

77.74

—

Hyperlipidaemia, other/unspecified

139

2.72

8.01

1.2

—

86.21

—

Asthma, unspecified (mode)

254

2.14

8.00

1.3

—

86.25

—

Other diseases of upper respiratory tract

134

395

1.77

7.97

1.2

75.42

86.95

mmol/24h

—

Mouth breathing

242

2.31

7.97

1.2

—

88.36

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

113

377

1.81

7.49

1.3

1.2

—

81.46

—

Asthma (diagnoses ohter than nonallergic)

108

506

1.77

7.17

1.3

—

78.89

—

Other and unspecified effects of external causes

169

2.49

7.05

1.1

1.3

—

96.20

—

Irritable bowel syndrome

152

2.57

6.99

1.3

1.2

—

95.90

—

Selective serotonin reuptake inhibitors

118

352

1.75

6.86

1.2

86.80

79.49

mmol/24h

—

Asthma (only as main-diagnosis), excluding more controls

264

1.91

6.83

1.3

—

86.25

—

Retention of urine

124

2.58

6.79

1.2

—

81.79

—

Asthma (only as main-diagnosis)

277

1.88

6.75

1.3

1.2

—

86.25

—

Acute tubulo-interstitial nephritis

328

1.95

6.68

1.2

—

82.29

—

Epilepsy

132

2.65

6.66

1.2

—

91.86

—

Other and unspecified myopathies

6.42

6.63

1.2

—

Other systemic involvement of connective tissue

140

2.58

6.51

1.1

1.2

—

85.82

—

IgA nephropathy (IgA glomerulonephritis)

14.43

6.40

1.7

1.4

—

269

2.07

6.13

1.3

1.2

—

82.65

—

Dermatitis

403

1.86

6.04

1.2

—

80.94

—

Convulsions, not elsewhere classified

116

2.64

5.90

1.2

—

78.28

—

L04AA Selective immunosuppressants

119

2.61

5.78

1.2

1.3

—

89.82

—

Migraine without aura

2.85

5.50

1.4

1.2

—

90.85

—

Diabetes, insulin treatment (Kela reimbursement)

114

423

1.63

5.38

1.3

1.2

—

82.87

—

Abdominal and pelvic pain

112

341

1.65

5.34

1.3

79.44

76.87

mmol/24h

—

Nerve, nerve root and plexus disorders

123

473

1.59

5.33

1.3

85.58

78.15

mmol/24h

—

3.09

5.33

1.3

—

99.48

—

STROKE

223

1.92

5.31

1.2

—

90.40

—

Dialysis

9.14

5.29

1.1

1.4

—

Asthma, hospital admission 2, infections

355

1.82

5.07

1.2

—

85.49

—

Asthma-related infections

355

1.82

5.07

1.2

—

85.49

—

Other/unspecified dorsalgia

204

2.09

4.93

1.3

—

87.24

—

Acute upper respiratory infections of multiple and unspecified sites

400

1.67

4.89

1.2

1.3

—

79.80

—

Other general symptoms and signs

8.94

4.75

1.1

1.6

—

Other functional intestinal disorders

232

1.96

4.69

1.1

1.2

—

96.20

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

157

2.22

4.68

1.2

—

73.69

—

Other and unspecified dermatitis

330

1.82

4.65

1.3

1.2

—

82.93

—

Implicit bacterial Sepsis

180

2.07

4.62

1.1

1.2

—

86.21

—

Implicit bacterial Sepsis

194

2.00

4.53

1.1

1.2

—

86.21

—

Insulin medication

302

1.78

4.52

1.3

1.2

—

89.11

—

Viral and other specified intestinal infections

103

2.47

4.38

1.2

1.3

—

90.85

—

Hypertrophic cardiomyopathy

7.54

4.35

1.1

1.3

—

Unspecified haematuria

183

1.99

4.35

1.4

1.2

—

79.26

—

Other aneurysm

7.53

4.35

1.2

1.4

—

Other and unspecified iron deficiency

170

2.12

4.31

1.3

1.2

—

91.26

—

Drug-induced adrenocortical insufficiency

11.77

4.28

1.0

1.3

—

Diseases of liver

198

2.02

4.25

1.4

1.2

—

87.33

—

Insulin, fast-acting or short human

206

1.99

4.18

1.4

1.3

—

91.18

—

Abnormal findings on examination of blood, without diagnosis

246

1.87

4.18

1.3

1.2

—

89.36

—

Insulin, fast-acting

201

1.99

4.09

1.4

1.3

—

91.18

—

Asthma, hospital admissions , main diagnosis only

518

1.57

4.08

1.3

1.2

—

78.89

—

Other dialysis

8.05

4.06

1.1

1.4

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.50

4.03

1.1

1.3

—

97.62

—

Contact with nonpowered hand tool

6.46

3.98

1.6

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

119

432

1.50

3.95

1.2

1.3

70.40

82.81

mmol/24h

—

Symptoms and signs involving the digestive system and abdomen

105

341

1.54

3.93

1.3

90.91

76.87

mmol/24h

—

Diverticular disease of intestine

270

1.68

3.93

1.2

79.80

87.49

mmol/24h

—

Suppurative and unspecified otitis media

201

1.90

3.78

1.5

1.2

—

83.43

—

Diseases of the ear and mastoid process

130

447

1.46

3.78

1.4

1.2

77.88

79.25

mmol/24h

—

Retinal haemorrhage

12.06

3.76

2.2

1.4

—

Obesity, other/unspecified

208

1.93

3.75

1.2

—

87.33

—

Suicide or other Intentional self-harm

142

2.12

3.63

1.2

1.3

—

96.20

—

Insulin, combination of fast acting with intermediate-acting or long-acting

354

1.65

3.59

1.3

1.2

—

88.40

—

Care involving use of rehabilitation procedures

406

1.61

3.58

1.2

1.3

—

79.55

—

Hypocalcemia

7.83

3.56

1.4

1.2

—

Carrier of infectious disease

7.82

3.56

1.4

—

Dronedarone medication

7.82

3.56

1.0

1.2

—

Other cataract

174

1.87

3.55

1.3

1.2

—

90.67

—

Calculus of lower urinary tract

5.31

3.51

1.4

1.2

—

Type 1 diabetes

118

2.20

3.48

1.6

1.3

—

97.17

—

Poisoning by medicine

119

2.19

3.43

1.1

1.3

—

96.20

—

Viral and other specified intestinal infections

155

1.99

3.32

1.2

1.3

—

89.27

—

Non-ischemic cardiomyopathy

117

2.07

3.31

1.2

—

80.33

—

Fungal Sepsis

8.60

3.26

1.3

—

Internal derangement of knee

233

1.80

3.22

1.2

—

103.33

—

Haemorrhoids and perianal venous thrombosis

163

1.96

3.20

1.2

—

95.49

—

Insulin, intermediate and long-acting

330

1.65

3.19

1.4

1.2

—

89.28

—

Small fibre neuropathy

6.40

3.19

1.1

1.4

—

Allergic asthma (mode), excluding more controls

127

2.08

3.17

1.3

—

89.59

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

186

1.88

3.13

1.2

1.3

—

89.27

—

Allergic asthma (mode)

128

2.07

3.11

1.3

—

89.59

—

Type 1 diabetes, wide definition, subgroup 1

2.25

3.11

1.5

1.3

—

97.00

—

Urticaria and erythema

230

1.78

3.10

1.1

1.3

—

87.33

—

Noninfective enteritis and colitis

298

1.68

3.05

1.3

1.2

—

86.85

—

Glaucoma-related operations

5.01

3.05

1.5

1.3

—

Gingival hyperplasia

5.86

3.02

1.1

1.3

—

Other bacterial intestinal infections

106

2.17

3.02

1.2

—

89.82

—

Other noninfective gastroenteritis and colitis

113

2.12

2.98

1.2

—

89.82

—

Panhypopituitarism

10.06

2.98

1.6

1.4

—

Any mental disorder

117

417

1.41

2.87

1.3

88.49

70.23

mmol/24h

—

Triptan medication for migraine, min. 3 purchases

320

1.55

2.81

1.3

79.40

75.10

mmol/24h

—

Poisoning by drugs, medicaments and biological substances

137

1.97

2.79

1.1

1.3

—

96.20

—

Nontoxic goitre/thyroid nodule

158

1.90

2.79

1.1

1.2

—

85.82

—

Asthma and allergy, excluding more controls

2.47

2.79

1.3

1.2

—

96.14

—

Pollen allergy

115

2.06

2.78

1.2

1.3

—

99.48

—

Ankylosing hyperostosis [Forestier]

8.40

2.75

1.0

1.2

—

Paraplegia, diplegia of upper limbs

8.37

2.75

1.4

1.2

—

Type 1 diabetes, wide definition

104

2.12

2.73

1.5

1.3

—

97.00

—

Disorders of choroid and retina

380

1.48

2.72

1.4

1.2

—

89.89

—

Other diseases of spinal cord

6.02

2.70

1.3

1.4

—

Benign neoplasm of other and unspecified sites

6.02

2.70

1.7

1.2

—

Other extrapyramidal and movement disorders in other diseases

112

2.06

2.66

1.5

1.2

—

89.82

—

Disorders of speech understanding and production

5.90

2.66

1.2

1.1

—

Retinal vascular occlusion

2.79

2.64

1.3

1.2

—

Retinal vascular disorders

2.79

2.64

1.3

1.2

—

Personality disorders, excluding more controls

147

1.91

2.64

1.1

1.3

—

79.93

—

Asthma and allergy

2.40

2.63

1.3

1.2

—

96.14

—

Urticaria

191

1.78

2.61

1.1

1.3

—

89.83

—

Biological medication for rheuma

2.15

2.60

1.5

1.3

—

97.62

—

Other and unspecified vascular occlusions

3.34

2.60

1.4

1.1

—

Duodenal ulcer

3.34

2.60

1.2

—

Sleep disorders

482

1.41

2.56

1.4

1.2

88.69

75.39

mmol/24h

—

Somnolence, stupor and coma

7.16

2.55

1.0

1.4

—

Simple and mucopurulent chronic bronchitis

7.16

2.55

1.4

1.1

—

Combinations of oral blood glucose lowering drugs

143

1.89

2.50

1.2

—

90.67

—

Acute pharyngitis

2.25

2.45

1.4

1.2

—

98.25

—

Cardiodefibrillation

180

1.77

2.44

1.3

1.2

—

82.23

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

247

1.65

2.44

1.3

—

85.66

—

Gastroduodenal ulcer

109

2.01

2.43

1.2

—

81.79

—

Secondary polycythaemia

6.28

2.37

1.2

1.1

—

Acute suppurative otitis media

149

1.82

2.37

1.6

1.3

—

89.27

—

Osteoporosis with pathological fracture (FG)

3.64

2.36

1.3

—

Other ill-defined and unspecified causes of mortality

4.12

2.36

1.3

1.2

—

Vascular disorders of the intestines

4.12

2.36

1.1

1.2

—

Stroke, including SAH

277

1.52

2.33

1.2

—

85.49

—

Insomnia

477

1.39

2.33

1.3

1.2

88.69

75.39

mmol/24h

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

359

1.50

2.32

1.2

—

84.43

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

105

2.00

2.30

1.0

1.3

—

75.12

—

Specific development disorders of speech and language

3.97

2.27

1.1

1.4

—

Osteoporosis

118

1.90

2.26

1.1

1.2

—

73.32

—

Sequelae of external causes of morbidity and mortality

134

1.87

2.26

1.1

1.3

—

87.63

—

Asthma-related pneumonia

185

1.73

2.25

1.2

—

87.54

—

Fracture of neck

3.90

2.25

1.1

1.3

—

Ill-defined and unknown causes of mortality

3.89

2.25

1.3

1.2

—

Asthma, hospital admissions 3, pneumonia

186

1.72

2.21

1.2

—

87.54

—

Asthma-related pneumonia or sepsis

186

1.72

2.21

1.2

—

87.54

—

Benign neoplasm: Skin of lower limb, including hip

5.58

2.21

1.0

1.3

—

Fall involving bed

5.57

2.21

1.4

1.2

—

Traumatic subarachnoid haemorrhage

5.57

2.21

1.0

1.1

—

Urethral stricture

5.56

2.21

1.2

1.4

—

Other retinal disorders

296

1.50

2.21

1.4

1.2

—

87.51

—

Polymyalgia rheumatica

2.50

2.18

1.2

—

Other disorders starting during childhood or adolescence

4.25

2.13

1.2

1.4

—

Benign neoplasm: Pancreas

5.02

2.07

1.6

1.2

—

Other diseases of pericardium

5.01

2.07

1.2

—

Normotensive glaucoma

2.91

2.07

1.1

1.2

—

Delirium, not induced by alcohol and other psychoactive substances

2.56

2.07

1.0

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

4.11

2.07

1.2

1.4

—

Inflammatory diseases of female pelvic organs

327

1.44

2.03

1.3

1.2

—

75.83

—

Other benign neoplasms of skin

215

1.63

2.02

1.2

—

83.92

—

Sub-endpoint used in defining T1D endpoints

153

1.74

1.96

1.6

1.3

—

94.13

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

383

1.38

1.94

1.2

1.3

84.99

77.23

mmol/24h

—

Triptan medication for migraine, single purchase ok

383

1.38

1.94

1.2

1.3

84.99

77.23

mmol/24h

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

4.54

1.93

1.2

1.4

—

Stroke, excluding SAH

262

1.48

1.93

1.2

—

85.49

—

Gout, FINNGEN

134

1.79

1.93

1.3

1.2

—

75.50

—

Embedded and impacted teeth

142

0.41

1.93

1.4

1.3

—

90.85

—

Specific development disorders of scholastic skills

4.49

1.92

1.2

1.7

—

Other enthesopathies

174

1.67

1.85

1.1

1.2

—

79.31

—

Extrapyramidal and movement disorders

205

1.61

1.85

1.4

1.2

—

86.59

—

Behavioural syndromes associated with physiological disturbances and physical factors

491

1.33

1.84

1.4

1.2

88.69

75.39

mmol/24h

—

Other disorders of optic [2nd] nerve and visual pathways

3.54

1.83

1.2

1.4

—

Other and unspecified glaucoma

3.53

1.83

1.3

1.2

—

Use of selegiline

4.18

1.82

1.2

1.3

—

Injuries to the neck

123

1.79

1.2

1.3

—

96.20

—

Ulcerative colitis

123

1.79

1.4

1.3

—

94.13

—

Medical treatment for female infertility

150

0.40

1.76

1.3

—

86.02

—

Clear cell adenocarcinoma of kidney

3.34

1.74

1.0

1.2

—

Inflammatory disease of uterus

2.03

1.74

1.2

1.3

—

99.48

—

Unspecified kidney failure

2.92

1.72

1.4

1.3

—

Psychiatric diseases

370

1.31

1.70

1.3

1.2

90.23

69.26

mmol/24h

—

Disorders of skin appendages

324

1.45

1.67

1.4

1.2

—

83.84

—

Personality disorders

172

1.63

1.66

1.1

1.3

—

87.70

—

Other female pelvic inflammatory diseases

1.93

1.64

1.2

—

88.82

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

240

1.47

1.62

1.2

—

85.29

—

Hypercalcemia

3.58

1.61

1.0

1.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

227

1.53

1.60

1.1

1.3

—

89.33

—

Squamous cell neoplasms and carcinomas of the skin

2.69

1.58

1.0

1.2

—

Presbycusis

2.31

1.57

1.1

1.3

—

Childhood asthma (age<16), excluding more controls

2.01

1.54

1.4

1.3

—

96.14

—

Inflammatory bowel disease

192

1.56

1.53

1.4

1.2

—

89.33

—

Seborrhoeic keratosis

100

1.80

1.52

1.2

—

91.45

—

Benign neoplasm of urinary organs

3.34

1.52

1.2

1.3

—

Sequelae of injuries, of poisoning and of other consequences of external causes

123

1.71

1.50

1.1

1.3

—

91.84

—

Erosion of teeth , including avohilmo

154

1.62

1.49

1.2

1.3

—

96.20

—

Salpingitis and oophoritis

1.81

1.47

1.5

1.2

—

87.02

—

Laparoscopic right hemicolectomy

3.13

1.44

1.0

1.3

—

L01XX Other antineoplastic agents

3.13

1.44

1.0

1.3

—

Childhood asthma (age<16)

1.94

1.41

1.4

—

96.14

—

Sequelae with surgical and medical care as external cause

1.82

1.41

1.2

1.3

—

89.82

—

Oxycodone

170

1.54

1.40

1.2

1.3

—

79.41

—

Disorders of adult personality and behaviour

189

1.54

1.39

1.2

1.3

—

87.70

—

Injuries to the knee and lower leg

115

514

1.24

1.39

1.2

1.3

—

78.89

—

Diseases of middle ear and mastoid

338

1.36

1.38

1.5

1.2

—

83.89

—

All influenza

127

1.65

1.36

1.2

—

87.63

—

Voice disturbances

135

1.63

1.35

1.4

1.2

—

87.32

—

Iridocyclitis

112

1.70

1.35

1.2

—

87.63

—

Sulfasalazine

167

1.56

1.33

1.4

1.2

—

88.87

—

Use of antiglaucoma preparations and miotics

2.50

1.30

1.2

—

Acute bronchiolitis

2.46

1.26

1.2

—

Fissure and fistula of anal and rectal regions

130

1.62

1.26

1.4

1.2

—

95.49

—

Intestinal stricture

162

1.54

1.25

1.2

1.3

—

87.63

—

Keratitis

219

1.46

1.25

1.2

—

89.33

—

Specific personality disorders

147

1.57

1.22

1.2

1.3

—

96.20

—

Long labour

144

0.53

1.19

1.4

1.3

—

99.34

—

Degenerative macular diseases

2.11

1.18

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

157

1.53

1.16

1.2

—

87.33

—

Pulmonary embolism

141

1.56

1.16

1.2

—

88.85

—

Pulmonary heart disease

141

1.56

1.16

1.2

—

88.85

—

Retinal detachments and breaks

198

1.47

1.16

1.4

1.2

—

85.49

—

Venous thromboembolism

305

1.36

1.15

1.3

1.2

—

84.75

—

Periodontitis

509

0.77

1.14

1.3

—

82.87

—

Alcohol dependence

142

1.55

1.14

1.0

1.2

—

95.49

—

Mycoses

142

1.55

1.14

1.3

—

89.82

—

Injury of muscle and tendon at lower leg level

1.85

1.13

1.1

1.2

—

91.84

—

Chronic periodontitis, including avohilmo

509

0.78

1.13

1.3

—

82.87

—

Symptoms and signs involving speech and voice

183

1.48

1.12

1.4

1.2

—

85.98

—

Other and unspecified urticaria

103

1.65

1.12

1.1

1.3

—

97.62

—

Superficial injury of lower leg

127

1.58

1.11

1.2

1.3

—

90.06

—

Disorders of sclera, cornea, iris and ciliary body

381

1.31

1.08

1.2

—

88.40

—

Glaucoma, exfoliation

2.19

1.08

1.0

1.2

—

Olecranon bursitis

2.28

1.03

1.0

1.3

—

Abdominal aortic aneurysm (AAA)

2.25

1.02

1.6

1.2

—

Nonorganic sleeping disorders

114

1.58

1.02

1.4

1.3

—

96.20

—

Candidiasis

171

1.46

1.01

1.3

1.2

—

89.83

—

Malignant neoplasm of digestive organs

169

0.61

0.99

1.1

1.2

—

90.29

—

Impacted teeth

119

0.52

0.99

1.3

—

90.85

—

Entropion and trichiasis of eyelid

0.00

0.97

0.0

1.2

—

Deviated nasal septum

174

1.44

0.94

1.0

1.2

—

95.21

—

ILD, hospital admissions 3, with pneumonia sepsis

2.22

0.93

1.7

1.1

—

Familial hypercholesterolemia, with ischemic heart disease

2.22

0.93

1.2

1.1

—

Benign neoplasm: Colon, unspecified

117

1.54

0.93

1.3

1.2

—

88.85

—

Postmenopausal osteoporosis with pathological fracture

2.15

0.91

1.0

1.2

—

Carcinoma in situ of skin

2.14

0.91

1.0

1.2

—

Chronic gastritis

134

1.49

0.91

1.4

1.2

—

75.96

—

Bacterial pneumonia, not elsewhere classified

194

0.64

0.91

1.1

1.2

—

89.36

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.60

0.90

1.4

1.2

—

99.48

—

Maternal care for other conditions predominantly related to pregnancy

141

1.46

0.87

1.3

—

90.16

—

Idiopathic gout

2.00

0.87

1.2

1.3

—

Alzheimer’s disease (Atypical or mixed)

1.99

0.86

1.3

—

Open wound of head

322

1.29

0.85

1.1

1.3

—

90.73

—

Other diseases of anus and rectum

154

1.43

0.82

1.3

1.2

—

95.49

—

Endometriosis of rectovaginal septum and vagina

1.88

0.81

1.5

1.3

—

Fracture of skull and facial bones

105

1.52

0.81

1.1

1.3

—

91.84

—

Bacterial pneumonia (organism specified)

236

0.69

0.80

1.2

—

89.36

—

5-aminosalicylic acid

106

1.51

0.78

1.2

1.3

—

100.08

—

Any death

300

0.76

0.77

1.2

—

85.49

—

Other and unspecified tonsillitis

189

1.33

0.76

1.4

1.2

—

88.48

—

Car occupant injured in other and unspecified transport accidents

1.52

0.75

1.2

—

96.20

—

Bipolar affective disorders

1.52

0.75

1.1

1.3

—

102.56

—

Colonic or urogenital fistula

149

1.41

0.75

1.4

1.2

—

87.63

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.10

0.74

1.2

1.3

—

IBD patients in KELA-register

116

1.47

0.74

1.4

1.3

—

97.62

—

DVT of lower extremities and pulmonary embolism

227

1.32

0.72

1.3

1.2

—

85.49

—

Ischaemic Stroke, excluding all haemorrhages

250

1.25

0.68

1.2

—

85.49

—

Benign neoplasm: Transverse colon

1.63

0.66

1.0

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

412

1.21

0.66

1.3

—

78.89

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

182

1.28

0.66

1.1

1.2

—

88.75

—

Atopic dermatitis, strict definition with reimbursement

190

1.32

0.65

1.3

1.2

—

89.27

—

Phlebitis and thrombophlebitis (not including DVT)

120

1.42

0.64

1.3

1.2

—

75.39

—

Non-allergic asthma (mode), excluding more controls

1.48

0.64

1.1

1.2

—

96.55

—

Chronic periodontitis, complicated

356

0.78

0.63

1.3

1.2

—

88.58

—

Herpesviral [herpes simplex] infections

155

1.36

0.62

1.1

1.2

—

93.14

—

Psoriasis

164

1.34

0.62

1.5

1.2

—

90.29

—

Non-allergic asthma (mode)

1.46

0.61

1.1

1.2

—

96.55

—

Bacterial pneumoniae

206

0.73

0.61

1.2

—

89.36

—

Endometriosis ASRM stages 1,2

105

1.43

0.60

1.3

1.2

—

99.48

—

Rheumatoid arthritis, including avohilmo

227

1.28

0.59

1.3

1.2

—

85.64

—

Acute pancreatitis

1.46

0.57

1.3

1.2

—

91.84

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.42

0.57

1.0

1.1

—

Inflammatory bowel disease, strict (require KELA)

123

1.38

0.57

1.4

1.3

—

97.62

—

Atopic dermatitis, strict definition

189

1.30

0.57

1.3

1.2

—

89.27

—

Other fall from one level to another

115

1.39

0.56

1.5

1.3

—

94.13

—

Myocardial infarction, without ST-elevation

187

0.73

0.54

1.1

1.2

—

79.26

—

Caries of enamel

519

0.86

0.53

1.1

1.3

65.18

86.97

mmol/24h

—

Other gastritis (incl. Duodenitis)

109

1.38

0.50

1.6

1.2

—

81.41

—

Degeneration of macula and posterior pole

192

1.24

0.50

1.2

—

77.78

—

Pediculosis, acariasis and other infestations

1.43

0.49

1.4

1.3

—

97.62

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

163

1.29

0.48

1.4

1.3

—

91.19

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1.45

0.46

1.0

1.3

—

Other obstetric conditions, not elsewhere classified

155

1.23

0.46

1.3

—

81.23

—

Acute pancreatitis (for exclusion)

1.38

0.45

1.3

—

91.84

—

Nasal polyp

1.40

0.44

1.5

1.2

—

98.57

—

ILD, hospital admissions 1, main diag only

1.37

0.44

1.7

1.3

—

Speech therapy

140

0.71

0.43

1.0

1.2

—

87.31

—

L01XE Protein kinase inhibitors

0.00

0.41

0.0

1.3

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.41

0.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

152

1.21

0.40

1.3

—

81.23

—

Other (seronegative) rheumatoid arthritis, wide

1.36

0.40

1.2

1.3

—

88.82

—

Complications predominantly related to the puerperium

171

0.76

0.39

1.3

1.2

—

89.60

—

Scabies

1.41

0.39

1.4

1.3

—

97.62

—

Seropositive rheumatoid arthritis

124

1.29

0.37

1.4

1.2

—

91.09

—

Primary_lymphoid and hematopoietic malignant neoplasms

112

0.71

0.37

1.4

1.2

—

89.82

—

Colorectal cancer

111

0.70

0.37

1.1

1.2

—

96.11

—

Periapical abscess

299

1.17

0.37

1.4

1.2

—

89.86

—

Viral warts

124

0.73

0.35

1.2

1.3

—

96.20

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1.32

0.33

1.1

1.2

—

92.55

—

Coxarthrosis, primary, with hip surgery

240

1.17

0.32

1.1

1.2

—

88.85

—

Other and unspecified disorders of vitreous body

244

1.17

0.32

1.2

—

86.91

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.33

0.32

1.3

—

97.62

—

Pre-eclampsia or eclampsia

138

1.23

0.30

1.2

—

89.60

—

Use of levodopa decarboxylase inhibitor

1.30

0.30

1.3

1.2

—

Effects of foreign body entering through natural orifice

129

1.24

0.30

1.1

1.3

—

92.87

—

Transient ischemic attack

248

1.14

0.28

1.1

1.2

—

85.49

—

Acute alcohol intoxication, ICD10

103

1.26

0.28

1.5

1.3

—

91.84

—

Obstructed labour due to malposition and malpresentation of fetus

151

0.80

0.28

1.2

1.3

—

85.12

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

202

1.14

0.27

1.1

1.2

—

88.75

—

Fall on and from stairs and steps

131

1.22

0.27

1.4

1.3

—

87.63

—

Disorders of vitreous body

299

1.13

0.26

1.1

1.2

—

82.66

—

Ulcerative colitis (strict definition, require KELA)

1.26

0.24

1.3

—

97.62

—

Fracture of lower leg, including ankle

357

1.11

0.23

1.2

1.3

—

89.84

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.24

0.22

1.2

1.3

—

97.62

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

134

1.19

0.22

1.4

1.2

—

84.96

—

Anomalies of dental arch relationship, including avohilmo

1.22

0.22

1.5

1.3

—

97.62

—

Benign neoplasm: Caecum

1.22

0.22

1.0

1.2

—

Other viral diseases

181

1.16

0.21

1.2

1.3

—

87.70

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.21

0.0

1.4

—

Aggressive periodontitis

0.00

0.21

0.0

1.3

—

Malignant cancer of tonsil and base of tongue, including Hilmo

0.00

0.21

0.0

1.4

—

Disorders of globe

0.00

0.21

0.0

1.4

—

Oral leukoplakia, including avohilmo

0.00

0.21

0.0

1.3

—

Adenocarcinoma of pancreas

0.00

0.21

0.0

1.3

—

Hodgkin lymphoma, hilmo

0.00

0.21

0.0

1.2

—

Malignant neoplasm of small intestine, including Hilmo

0.00

0.21

0.0

1.3

—

Renal cell carcinoma of kidney

0.00

0.21

0.0

1.3

—

Other specified and unspecified retinal disorders

0.00

0.21

0.0

1.3

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.21

0.0

1.3

—

Other congenital malformations of the digestive system

0.00

0.21

0.0

1.3

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

0.21

0.0

1.4

—

Strabismus

144

1.18

0.21

1.1

1.2

—

91.97

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

0.00

0.21

0.0

1.3

—

Acute alcohol intoxication ICD-9

0.00

0.21

0.0

1.3

—

Other disorders of male genital organs

0.00

0.21

0.0

1.3

—

Alzheimer’s disease (Early onset)

0.00

0.21

0.0

1.3

—

Transient global amnesia

1.16

0.21

1.0

1.2

—

Myelodysplastic syndrome, including Hilmo

0.00

0.21

0.0

1.2

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.21

0.0

1.4

—

Non-Hodgkin lymphoma, all

0.00

0.21

0.0

1.2

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.20

0.0

1.3

—

Follicular lymphoma, hilmo

0.00

0.20

0.0

1.3

—

Non-small cell lung cancer, squamous

0.00

0.20

0.0

1.2

—

Other congenital malformations of the digestive system

0.00

0.20

0.0

1.4

—

Other/unspecified seropositive rheumatoid arthritis

136

1.18

0.20

1.4

1.2

—

84.96

—

Eating disorder

1.22

0.20

1.2

1.3

—

99.48

—

Disorders of vitreous body and globe

304

1.11

0.19

1.1

1.2

—

82.66

—

Basal cell carcinoma

179

1.12

0.19

1.1

1.2

—

88.75

—

Haemorrhage in early pregnancy

188

1.14

0.19

1.5

1.2

—

83.78

—

Dementia in Alzheimer disease

1.18

0.18

1.6

1.2

—

Basal cell carcinoma, including avohilmo

186

1.11

0.18

1.1

1.2

—

88.75

—

Eating disorders

1.18

0.18

1.6

1.3

—

99.48

—

Seropositive rheumatoid arthritis, wide

138

1.16

0.17

1.4

1.2

—

84.96

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.11

0.17

1.6

1.2

—

99.48

—

Pre-eclampsia

129

1.16

0.17

1.2

—

89.60

—

Emotionally unstable personality disorder

1.16

0.16

1.0

1.3

—

99.48

—

Persons encountering health services in circumstances related to reproduction

306

0.92

0.16

1.3

96.13

82.51

mmol/24h

—

Other disorders of bone

111

1.17

0.15

1.0

1.3

—

91.84

—

Alcohol abuse, main dg

1.21

0.15

1.5

1.3

—

91.84

—

Superficial injury of head

121

1.16

0.15

1.2

1.3

—

89.82

—

Other medical care

247

0.91

0.14

1.2

—

87.51

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

126

0.86

0.13

1.0

1.2

—

90.29

—

Other predominantly sexually transmitted diseases, not elsewhere classified

107

0.84

0.13

1.3

—

99.48

—

Striking against or struck by other objects

200

1.10

0.12

1.3

—

93.99

—

Sequelae of cerebrovascular disease

156

1.11

0.12

1.2

1.3

—

91.84

—

Liquid cancers, helper endpoint

192

0.91

0.12

1.3

1.2

—

90.29

—

Abnormal findings on diagnostic imaging of lung

258

1.08

0.11

1.1

1.2

—

84.75

—

Nonsuppurative otitis media

124

1.12

0.11

1.4

1.2

—

90.85

—

Other predominantly sexually transmitted diseases, not elsewhere classified

136

0.88

0.11

1.3

—

90.85

—

Infections with a predominantly sexual mode of transmission

261

1.07

0.10

1.2

1.3

—

82.47

—

1.09

0.08

1.3

—

99.48

—

Parkinson's disease, strict definition

1.07

0.08

1.2

—

Other sexually transmitted chlamydial diseases

1.08

0.08

1.1

1.3

—

79.37

—

Use of donepezil

0.86

0.07

1.3

1.2

—

Acute alcohol intoxication

137

1.10

0.07

1.5

1.3

—

95.49

—

LSIL lesion of the cervix uteri, vagina or vulva

1.06

0.07

1.1

1.3

—

99.48

—

Infections with a predominantly sexual mode of transmission

203

0.93

0.06

1.2

1.3

—

83.43

—

Myocardial infarction

193

0.95

0.06

1.3

1.2

—

85.49

—

Fitting and adjustment of other devices

180

1.05

0.04

1.1

1.2

—

86.59

—

Unspecified mental disorder

272

1.03

0.02

1.2

1.3

—

90.94

—

Other strabismus

116

0.94

0.01

1.0

1.2

—

94.32

—

Abnormal serum enzyme levels

152

0.96

0.00

1.3

1.2

—

92.87

—

Special screening examination for infectious and parasitic diseases

125

1.00

0.00

1.1

1.4

—

79.31

—

Myocardial infarction, strict

174

0.98

0.00

1.3

1.2

—

85.49

—

Kela-code for severe mental illness

241

1.00

0.00

1.3

—

90.94

—

Covid-19 suspected case

128

1.02

0.00

1.2

—

96.20

—

Organic, including symptomatic, mental disorders

201

0.99

0.00

1.3

1.2

—

74.40

—

Injury of muscle and tendon at shoulder and upper arm level

212

0.99

0.00

1.1

1.2

—

88.85

—

Dermatophytosis

447

1.01

0.00

1.3

—

86.53

—

LSIL lesion of the cervix uteri

0.95

0.00

1.0

1.3

—

99.48

—

Pyogenic granuloma

0.00

0.0

1.4

—

Overjet

0.00

0.0

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.00

0.0

1.4

—

Pulmonary eosinophilia, not elsewhere classified

0.00

0.0

1.3

—

Hypothyroidism due to medicaments and other exogenous substances

0.00

0.0

1.2

—

Encephalopathy

0.00

0.0

1.0

—

Benign neoplasm: Appendix

0.00

0.0

1.4

—

Viral conjunctivitis

0.00

0.0

1.3

—

Mesothelioma, including Hilmo

0.00

0.0

1.4

—

Congenital deformities of hip

0.00

-0.00

0.0

1.4

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

-0.00

0.0

1.2

—

Keratoconus

0.00

-0.00

0.0

1.3

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of parotid gland

0.00

-0.00

0.0

1.4

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of tonsil

0.00

-0.00

0.0

1.3

—

Corneal degeneration

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of oropharynx

0.00

-0.00

0.0

1.3

—

Parkinson's disease

1.00

-0.00

1.2

—

Discitis, unspecified

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of parotid gland, including Hilmo

0.00

-0.00

0.0

1.3

—

Melanocytic naevi of upper limb, including shoulder

0.00

-0.00

0.0

1.3

—

Retinoschisis and retinal cysts

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Vagina

0.00

-0.00

0.0

1.4

—

Malignant cancer of tonsil and base of tongue

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of small intestine

0.00

-0.00

0.0

1.3

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

-0.00

0.0

1.4

—

Marginal zone B-cell lymphoma, including Hilmo

0.00

-0.00

0.0

1.3

—

Guillain-Barre syndrome

0.00

-0.00

0.0

1.2

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

-0.00

0.0

1.2

—

Alcohol abuse counselling and surveillance

0.00

-0.00

0.0

1.4

—

Ankle and foot

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of tonsil, including Hilmo

0.00

-0.00

0.0

1.3

—

Need for immunization against other single viral diseases

0.00

-0.00

0.0

1.3

—

Shoulder region

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of anus and anal canal, including Hilmo

0.00

-0.00

0.0

1.4

—

Hypertrophy of tongue papillae

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of other and unspecified female genital organs

0.00

-0.00

0.0

1.3

—

Small cell lung cancer

0.00

-0.00

0.0

1.4

—

Colorectal neuroendocrine tumor and carcinoma

0.00

-0.00

0.0

1.3

—

Superficial injury of neck

0.00

-0.00

0.0

1.2

—

Marginal zone B-cell lymphoma

0.00

-0.00

0.0

1.2

—

Donors of organs and tissues

0.00

-0.00

0.0

1.5

—

Helminthiases

0.00

-0.00

0.0

1.6

—

Androgenic alopecia

0.00

-0.00

0.0

1.4

—

Gastrointestinal stromal tumor and sarcoma

0.00

-0.00

0.0

1.4

—

Amputation of thigh

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.00

-0.00

0.0

1.4

—

Leiomyosarcoma, including Hilmo

0.00

-0.00

0.0

1.3

—

Dermatopolymyositis

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of eye and adnexa, including Hilmo

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of larynx, including Hilmo

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of gum, including Hilmo

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of rectosigmoid junction

0.00

-0.00

0.0

1.3

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

0.00

-0.00

0.0

1.3

—

Multiple myeloma

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Other and unspecified parts of small intestine

0.00

-0.00

0.0

1.2

—

Small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.4

—

Oesophageal obstruction

0.00

-0.00

0.0

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

0.00

-0.00

0.0

1.3

—

Other diseases of appendix

0.00

-0.00

0.0

1.2

—

Other melanin hyperpigmentation

0.00

-0.00

0.0

1.4

—

Small cell lung cancer, helper endpoint

0.00

-0.00

0.0

1.4

—

Communicating hydrocephalus

0.00

-0.00

0.0

1.1

—

Other bursitis of knee

0.00

-0.00

0.0

1.2

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.00

-0.00

0.0

1.3

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.5

—

Unspecified nephritic syndrome

0.00

-0.00

0.0

1.3

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.5

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.5

—

HSIL lesion of the vulva

0.00

-0.00

0.0

1.3

—

Monoplegia

0.00

-0.00

0.0

1.2

—

Anomalies of pupillary function

0.00

-0.00

0.0

1.2

—

Inguinal hernia, unilateral

0.00

-0.00

0.0

1.5

—

Alcoholic gastritis

0.00

-0.00

0.0

1.4

—

Benign neoplasm: other/unspecified salivary gland

0.00

-0.00

0.0

1.3

—

Neuroendocrine tumor and carcinoma of lung

0.00

-0.00

0.0

1.2

—

Myeloid leukaemia

0.00

-0.00

0.0

1.3

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

-0.00

0.0

1.3

—

Injury of eye and orbit

0.96

-0.00

1.1

1.3

—

91.84

—

Other disorders of prostate

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Brain, supratentorial

0.00

-0.00

0.0

1.2

—

Accidental poisoning by and exposure to alcohol

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

-0.00

0.0

1.3

—

Synovial hypertrophy, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Portal vein thrombosis

0.00

-0.00

0.0

1.1

—

Amputation of ankle bones

0.00

-0.00

0.0

1.3

—

Other infestations

0.00

-0.00

0.0

1.3

—

Disorders of acoustic nerve

0.00

-0.00

0.0

1.2

—

Embolic stroke with flimmer

0.00

-0.00

0.0

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Potassium [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS